Stocklytics Platform

Score (Market)

publish
The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions.
name
arrow_downwardScore languageValue languageQuality languageOwnership languageGrowth languageDividends languagePrice % Change
Asset logo for symbol GDOT
GDOTGreen Dot
$11.80arrow_drop_down5.60%AI Analysis
Asset logo for symbol SNSE
SNSESensei Biotherapeutics
$0.53arrow_drop_up6.00%AI Analysis
Asset logo for symbol RELI
RELIReliance Global Group
$2.31arrow_drop_down3.34%AI Analysis
Asset logo for symbol COCP
COCPCocrystal Pharma
$1.73arrow_drop_down3.35%AI Analysis
Asset logo for symbol LANV
LANVLanvin Group Holdings Limited
$1.790.00%AI Analysis
Asset logo for symbol CRKN
CRKNCrown ElectroKinetics
$1.18arrow_drop_down0.84%AI Analysis
Asset logo for symbol HRT
HRTHireRight Holdings Corporation
$14.36arrow_drop_down0.13%AI Analysis
Asset logo for symbol VZLA
VZLAVizsla Silver
$2.04arrow_drop_up6.25%AI Analysis
Asset logo for symbol QDEL
QDELQuidel
$45.39arrow_drop_up1.45%AI Analysis
Asset logo for symbol NVOS
NVOSNovo Integrated Sciences
$0.30arrow_drop_up2.69%AI Analysis
Asset logo for symbol WLYB
WLYBJohn Wiley & Sons
$46.760.00%AI Analysis
Asset logo for symbol SNAP
SNAPSnap
$10.57arrow_drop_up3.62%AI Analysis
Asset logo for symbol PHAR
PHARPharming Group N.V.
$7.60arrow_drop_down0.75%AI Analysis
Asset logo for symbol EDR
EDREndeavor Group Holdings
$28.25arrow_drop_up1.21%AI Analysis
Asset logo for symbol LOCL
LOCLLocal Bounti Corporation
$2.14arrow_drop_down2.72%AI Analysis
Asset logo for symbol LYRA
LYRALyra Therapeutics
$0.27arrow_drop_up0.36%AI Analysis
Asset logo for symbol ONCY
ONCYOncolytics Biotech
$0.90arrow_drop_down1.09%AI Analysis
Asset logo for symbol CVKD
CVKDCadrenal Therapeutics
$11.90arrow_drop_up16.94%AI Analysis
Asset logo for symbol SITM
SITMSiTime
$164.86arrow_drop_up0.94%AI Analysis
Asset logo for symbol OMQS
OMQSOMNIQ
$0.170.00%AI Analysis
Showing 3981-4000 of 4976
Results per page:

When making investment decisions, a holistic view is essential. The Stocklytics Score provides just that—ranking stocks based on five key factors to give you a comprehensive evaluation. With our Market Score, stocks are ordered by our proprietary scoring system, so you can quickly identify top opportunities. The Stocklytics Score is a powerful combination of: - Value Scoring – Find stocks that offer the best value based on fundamental metrics like price-to-earnings and price-to-sales ratios. - Quality Scoring – Invest with confidence by identifying high-quality companies with strong financials and consistent performance. - Ownership Scoring – Analyze institutional and insider ownership to get a sense of the confidence level from key stakeholders. - Growth Scoring – Discover companies with the potential for above-average earnings and revenue growth. - Dividends Scoring – Focus on stocks with strong dividend yields and sustainable payout ratios for long-term income generation. The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions. Why Use the Stocklytics Score? - Comprehensive View: Assess multiple factors at once to get a balanced perspective. - Data-Driven: Rely on a scoring system built from reliable financial data and market insights. - Actionable Rankings: Prioritize stocks based on their overall score or by individual factors like value or growth.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level